NCT00210821View on ClinicalTrials.gov

Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches

PHASE3CompletedINTERVENTIONAL
Enrollment

347

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

November 30, 2005

Conditions
MigraineHeadache
Interventions
DRUG

topiramate

All Listed Sponsors
collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00210821 - Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine Headaches | Biotech Hunter | Biotech Hunter